Tag: CDC

Categories
Health

CDC group says there is not sufficient information but to suggest booster pictures

CDC group says there isn't enough data yet to recommend booster shots

A group of Centers for Disease Control and Prevention scientists said Wednesday that currently there isn’t enough data to support recommending Covid-19 booster shots to the general population but that more-vulnerable groups, such as elderly people or transplant recipients, may need an extra dose.

The Covid-19 working group of the CDC’s Advisory Committee on Immunization Practices didn’t rule out the possibility that the general population eventually may need booster shots if immunity from the vaccines wanes or a variant reduces the effectiveness of current shots.

“Boosters may be required for a broad population. However, it could also be that the need for boosters of Covid vaccine may only be demonstrated in some populations,” said Dr. Sarah Oliver, co-lead of the working group and a medical epidemiologist with the CDC’s National Center for Immunization and Respiratory Diseases.

A recent study by researchers at Johns Hopkins University published in the Annals of Internal Medicine showed that booster shots may be beneficial for people with weakened immune systems. Oliver said the agency should monitor residents of long-term care facilities, elderly people, health-care workers and immunocompromised people.

The working group recommended that the CDC consider booster shots only “after evidence of declining protection,” Oliver said, meaning if the vaccines became less effective over time or antibodies guarding against Covid waned over time. The agency could also consider using booster shots if a variant emerged that substantially reduced the effectiveness of the vaccine.

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

Dado Ruvic | Reuters

“I would have to agree with the interpretation of the working group in the sense that there’s no data to support recommendations to support boosters at this time,” said Dr. Sharon Frey, a member of ACIP and clinical director of the Center for Vaccine Development at Saint Louis University Medical School. “There’s no evidence against declining protection at this time.”

But Frey said she would be open to giving a third shot to transplant patients or if infections rise in the general population, indicating a lot of breakthrough cases in fully vaccinated individuals. So far, there have been at least 3,729 breakthrough infections in the U.S. that resulted in hospitalization or death, according to CDC data.

“I think the only thing we can do at this moment is, if we start to see an uptick in reinfection in people or new infections in people who have been vaccinated, that’s our clue that we need to move quickly,” Frey said.

Dr. Grace Lee, who chairs the ACIP safety group and is a professor of pediatrics at Stanford University School of Medicine, also said she would like to see more evidence of breakthrough cases before recommending a booster shot.

“I would want greater certainty on the safety data if we’re talking about boosting before it’s clear what the risk data will look like,” Lee said. “If we’re seeing severe breakthrough cases then I think the decision-making moves forward even if there’s uncertainty with the safety data.”

Categories
Health

CDC says there’s seemingly hyperlink between uncommon coronary heart irritation in younger folks after Covid shot

CDC says there's likely link between rare heart inflammation in young people after Covid shot

A CDC safety group said there was a “likely link” between rare heart inflammation in adolescents and young adults, mostly after they received their second Covid-19 vaccine, citing the latest available data.

There have been more than 1,200 cases of myocarditis or pericarditis, mostly in those under 30 who have the Covid- Vaccine received from Pfizer or Moderna have practices methods exercises.

Myocarditis is the inflammation of the heart muscle while pericarditis is the inflammation of the membrane that surrounds the heart.

“The clinical picture of myocarditis cases after vaccination was variable and most often appeared within a week of the second dose, with chest pain being the most common,” said Dr. Grace Lee, Chair of the Committee’s Security Group. CDC officials are collecting more data to fully understand the potential risks, how to deal with them and if there are any long-term issues, she said.

Zoom In Icon Arrows pointing outwards

The agency said 267 cases of myocarditis or pericarditis were reported after receiving one dose of the mRNA vaccines and 827 cases after two doses by June 11. There are 132 additional cases where the number of doses received is unknown, the CDC said.

The agency announced that around 300 million shots had been administered by June 11.

“This is still a rare occurrence,” said Dr. Tom Shimabukuro at the meeting. For both vaccines combined, there were 12.6 cases of heart inflammation per million doses. Cases were more common among Moderna vaccine recipients at 19.8 cases per million than eight cases per million at Pfizer, he said.

Men under 30 make up the bulk of cases, the CDC said, and most cases appear to be mild. Of the 295 people who developed the disease and were discharged, 79% made a full recovery, according to the presentation. Nine people were hospitalized, according to the agency, two of them in the intensive care unit.

CDC officials said the benefits of the Covid vaccine still outweigh the risks.

Cases in younger people are increasing as older people are vaccinated at higher rates. The US vaccinated 177.6 million people with at least one dose, according to the CDC, that’s about 53% of the population. Only 13.6% of 18- to 24-year-olds in the United States received at least one dose of vaccine, compared with 26% of people ages 50 to 64, the data shows.

While hospitalization rates have decreased in older age groups, they have barely moved in adolescents and young adults, said Dr. Megan Wallace from the CDC.

“Teenagers and young adults make up a larger proportion of the total cases, 33% of the cases reported in May were people ages 12-29, compared with 28% last December,” she said. Since the pandemic began, 2,767 people aged 12 to 29 have died of Covid, she said, noting that 316 of these deaths had occurred since April 1.

The CDC is coordinating its investigation with the Food and Drug Administration, which last month approved the Pfizer BioNTech vaccine for adolescents ages 12-15. Symptoms like chest pain and shortness of breath usually develop within a week of receiving the vaccination, with most developing within four days, the agency said.

This is a developing story. Please check again for updates.

CNBC’s Rich Mendez contributed to this article.

Correction: Most of the cases of people who had myocarditis occurred in people under the age of 30. In a previous version, the age was incorrectly stated. The number of cases per million doses administered was 12.6. In an earlier version, the number was incorrectly specified.

Categories
Health

C.D.C. Advisers to Focus on Uncommon Coronary heart Issues in Vaccinated Youth

C.D.C. advisers are expected to discuss rare heart problems in vaccinated younger people.

Advisors to the Centers for Disease Control and Prevention will meet on Wednesday to address reports of rare heart problems in young people immunized with Pfizer-BioNTech and Moderna’s coronavirus vaccines.

The reports pertain to conditions called myocarditis, inflammation of the heart muscle; and pericarditis, inflammation of the membrane surrounding the heart. Most of the cases were mild, with symptoms such as fatigue, chest pain, and irregular heartbeat that go away quickly. The agency is tracking nearly 800 reports, although not all of them have definitely been linked to the vaccines.

The CDC advisors meeting comes as the Biden administration publicly recognizes it expects to miss its goal of partially immunizing 70 percent of Americans by July 4th.

Experts have said that the benefits of vaccination far outweigh the risk of potential problems, but they are expected to revisit this debate, especially for adolescents and young adults.

More than half of heart problems were reported in Americans ages 12 to 24, while that age group accounted for only 9 percent of the millions of doses given. The numbers are higher than one would expect for this age.

As of May 31, 216 people had developed myocarditis or pericarditis after a dose of either vaccine and 573 after the second dose. While most of the cases were mild, 15 patients remained in hospitals at this point. The second dose of Pfizer BioNTech vaccine was associated with approximately twice as many cases as the second dose of Moderna’s vaccine.

“We look forward to more clarity about the potential risk of myocarditis after mRNA vaccines in order to increase vaccination confidence and rates,” said Dr. Yvonne Maldonado, Chair of the Committee on Infectious Diseases at the American Academy of Pediatrics.

Recommendations from CDC advisors after Wednesday’s meeting may also influence decisions about immunizing children under 12 if vaccines are available for that age group. Some experts have questioned whether the benefits to children outweigh the potential risks given the low likelihood of serious illness in young children.

The CDC strongly recommends Covid-19 vaccines for Americans 12 and older. The agency reported this month that Covid-19-related hospitalizations among teenagers in the United States were about three times higher than influenza-related hospitalizations for the past three flu seasons.

By June 10, according to the American Academy of Pediatrics, nearly 17,000 children in 24 states had been hospitalized for Covid-19 and 330 children had died.

Categories
Health

C.D.C. advisers are anticipated to debate uncommon coronary heart issues in vaccinated youthful individuals.

C.D.C. advisers are expected to discuss rare heart problems in vaccinated younger people.

Advisors from the Centers for Disease Control and Prevention are due to meet on Wednesday to discuss reports of rare heart problems in young people immunized with Pfizer-BioNTech and Moderna’s coronavirus vaccines.

The reports pertain to conditions called myocarditis, inflammation of the heart muscle; and pericarditis, inflammation of the membrane surrounding the heart. Most of the cases were mild, with symptoms such as fatigue, chest pain, and irregular heartbeat that go away quickly. The agency is tracking nearly 800 reports, although not all of them have definitely been linked to the vaccines.

The CDC advisors meeting comes as the Biden administration publicly recognizes it expects to miss its goal of partially immunizing 70 percent of Americans by July 4th.

Experts have said that the benefits of vaccination far outweigh the risk of potential problems, but they are expected to revisit this debate, especially for adolescents and young adults.

More than half of heart problems were reported in Americans ages 12 to 24, while that age group accounted for only 9 percent of the millions of doses given. The numbers are higher than one would expect for this age.

As of May 31, 216 people had developed myocarditis or pericarditis after a dose of either vaccine and 573 after the second dose. While most of the cases were mild, 15 patients remained in hospitals at this point. The second dose of Pfizer BioNTech vaccine was associated with approximately twice as many cases as the second dose of Moderna’s vaccine.

“We look forward to more clarity about the potential risk of myocarditis after mRNA vaccines in order to increase vaccination confidence and rates,” said Dr. Yvonne Maldonado, Chair of the Committee on Infectious Diseases at the American Academy of Pediatrics.

Recommendations from CDC advisors after Wednesday’s meeting may also influence decisions about immunizing children under 12 if vaccines are available for that age group. Some experts have questioned whether the benefits to children outweigh the potential risks given the low likelihood of serious illness in young children.

The CDC strongly recommends Covid-19 vaccines for Americans 12 and older. The agency reported this month that Covid-19-related hospitalizations among teenagers in the United States were about three times higher than influenza-related hospitalizations for the past three flu seasons.

By June 10, according to the American Academy of Pediatrics, nearly 17,000 children in 24 states had been hospitalized for Covid-19 and 330 children had died.

Categories
Health

C.D.C Research Say Younger Adults Are Much less Prone to Get Vaccinated

C.D.C Studies Say Young Adults Are Less Likely to Get Vaccinated

Younger Americans are less likely to be vaccinated than older ones, and factors such as income and education can affect vaccination reluctance, according to two new studies from the Centers for Disease Control and Prevention.

By May 22, 57 percent of adults had received at least one dose of vaccine, the authors found in one of the new publications, but the rate fluctuated widely depending on age: of those 65 or older, 80 percent were at least partially vaccinated, compared with 38 Percent of 18 to 29 year olds.

Part of the rate gap was due to the fact that many young adults were not eligible for vaccination until March or April. But uptake has also been slower among younger Americans, and a significant proportion of them remain hesitant.

If vaccination initiation rates remain stable, only 58 percent of 18- to 29-year-olds will be vaccinated by the end of August, compared with 95 percent of 65-year-olds, the researchers found.

Immunization rates have lagged among young men, people who live in rural counties, and people who live in counties where a high proportion of the population is low-income, uninsured, or without access to a computer or the Internet.

In a second study, 24.9 percent of the 18 to 39-year-olds questioned said that they would probably or definitely not get vaccinated. Those who were young, black, low-income, had no health insurance, lived outside of metropolitan areas, or had a lower level of education were less likely to say they had vaccinated or said they were definitely planning to vaccinate.

The studies highlight the hurdles remaining in improving vaccination coverage, two weeks to President Biden’s self-imposed July 4 deadline to get 70 percent of adults at least partially vaccinated. In recent weeks, his government has changed its approach by moving away from mass vaccination centers and adopting more targeted strategies, including setting up mobile or pop-up vaccination clinics and on-site vaccination events in black barbershops.

The US vaccination campaign began on December 14th. Healthcare workers, adults aged 75 and over, and members of other high-risk groups were generally the first to be considered, although vaccination guidelines varied from state to state. By April 19, all adults were eligible for the recordings. Using the vaccination data submitted by the states, a team of CDC researchers analyzed vaccination patterns across demographic groups.

They also calculated the percentage of people in each age group who received their first dose during a given week. This “initiation rate” of the vaccine was highest in adults aged 65 and over, peaking the week of February 7, when 8 percent of adults in this group received their first dose.

Between April 19 and May 22, the proportion of 18 to 29 year olds who received their first dose fell from 3.6 percent to 1.9 percent.

“If the current vaccination rate continues through August, vaccination rates will remain significantly lower in young adults than in older adults,” the researchers wrote.

In the second study, between March 5 and May 2, the researchers interviewed a nationally representative sample of adults, including 2,726 18- to 39-year-olds. Of those who said they probably or definitely would not get the vaccine, 57 percent said they didn’t trust the vaccine, while 56 percent expressed concern about possible side effects and 36 percent said they didn’t need the vaccine.

The study also suggested possible strategies for increasing vaccination coverage. Of those who said they were unsure or likely to get the vaccine, 20 to 40 percent said they would be more likely to get it if they had more information about its safety and effectiveness if it would prevent them from doing so. spreading the virus to family and friends, or when it would allow them to return to normal social activities.

Categories
Health

Covid Proved the C.D.C. Is Damaged. Can It Be Fastened?

Covid Proved the C.D.C. Is Broken. Can It Be Fixed?

MacCannell says he did everything he could to get the crisis under control: he and his team developed protocols to help public health labs launch new sequencing programs; developed plans to collaborate with commercial laboratories, which have a much larger overall capacity; and set up a consortium of scientists across the country to collaborate and pool resources. But those efforts are only stopgaps, he admits, and in any case, the approval and funding required to get started was delayed by many months. “There was a big gap between what we expected and what we actually saw,” says MacCannell. “Not just at the federal level, but at every step from there.”

Genomic surveillance is one of many shortcomings that plague the disease surveillance system that the CDC presides over. These deficiencies are invisible to anyone who does not work in the field, because at first glance the system makes sense. Public health emergencies identified at the local level are reported to state health officials and then passed on to the CDC as necessary, where officials analyze the information, issue guidelines, and coordinate federal action. There is a special system for the 120 or so “reportable diseases” – like Lyme disease and hepatitis – all of which agree are serious enough to warrant immediate action, and another for “syndromic surveillance,” according to the epidemiologist Search the emergency room in real time can search data on symptoms of concern. But under this broad structure there is often chaos.

As the coronavirus turned into a full blown pandemic, CDC scientists struggled to answer even basic questions about what the disease looked like or where or how it spread.

The system itself is profoundly disjointed and the technology behind it is less mature than many American households. State health departments are not meaningfully linked, nor are hospitals, clinics, laboratories and local health authorities. The CDC maintains more than 100 separate disease-specific computer systems (a by-product of the agency’s funding silos), and many of them cannot communicate with one another. Critical data is often passed from health facilities to health departments through a tortured process that can include handwritten notes, manual spreadsheets, fax machines, and mail. It is not uncommon for basic information such as race, ethnicity, age, or address to be missing from clinical reports. It’s also not uncommon for these reports to wane at the state or local level without ever getting to federal officials. Even the most serious diseases, which should be logged within 24 hours of their discovery and reported to the CDC in good time, are not necessarily systematically routed into this chain. “It depends on the jurisdiction,” Janet Hamilton, executive director of the State and Territorial Epidemiologists Council, recently told me. “Some regions have solid health departments and good reporting, while others don’t.”

Disease surveillance is also hampered by the uneven patchwork of surveillance programs across the country and the need to negotiate data sharing and other agreements with each state separately. Antibiotic resistance, respiratory infections and other pathogens are being tracked robustly in some areas and very poorly or not at all in others (for example, respiratory infections are monitored more closely in the Four Corners region than elsewhere), partly because the agency does not have the ability or authority to obtain all of the data it needs every community. Hanage compares the entire apparatus with a Rube Goldberg machine. “There is nothing central,” he says. “Random patchwork collaborations were initiated and transformed and are now having an overwhelming impact on our understanding of public health. Don’t let that criticize the people who did these things because the alternative couldn’t have been anything. But the result is something without a rational plan behind it. “

The loopholes make it difficult to track even known diseases and barely get a grip on new ones. During a recent romaine lettuce E. coli outbreak, officials were forced to make billion-dollar life or death decisions about which products to pull from which shelves in which regions of the country, based on data that included screenshots and text-messages to epidemiologists and health authorities. During the 2019 Vaping Injury (or Evali) outbreak, doctors faxed hundreds of pages of medical records directly to local health officials in some cases. Epidemiologists could hardly process the data in this format, let alone analyze it for clues. “There’s no pre-built process when something like a vaping injury or Zika or SARS-CoV-2 comes up,” says Hamilton. “There are 64 different public health jurisdictions in this country, and each will have their own ideas about what information should be collected and shared.”

In 2020, as the coronavirus went from a few isolated outbreaks to a full-blown pandemic, CDC scientists struggled to answer even basic questions about what the disease itself looked like or where or how it spread. “We were asked who is being hospitalized, who are the severe cases, what are the characteristics, and it was so frustrating,” Anne Schuchat, the agency’s deputy director, told a panel of colleagues last fall. “People went out to check graphs manually. I felt like the health sector has this data. It’s in their system. Can we work with them? ”The agency was unable to reliably track the number of tests or cases across the country. It also struggled to update hospital records, which include things like bed availability and ventilator supplies. The Trump administration hired a private contractor to collect this data on charges of political favoritism. And when multiple vaccines were eventually deployed, the agency was unable to monitor supplies or keep a close eye on waste.

Categories
Health

Mother and father and caregivers reported psychological well being points extra usually than others through the pandemic, a C.D.C. examine says.

Parents and caregivers reported mental health issues more often than others during the pandemic, a C.D.C. study says.

Parents and unpaid caregivers of adults in the United States reported far higher rates of mental health issues during the coronavirus pandemic than people who held neither of those roles, federal researchers reported on Thursday.

About 70 percent of parents and adult caregivers — such as those tending to older people, for example — and about 85 percent of people who were both reported adverse mental health symptoms during the pandemic, versus about a third of people who did not hold those responsibilities, according to new research by the Centers for Disease Control and Prevention.

The study also found that people who were both parent and caregivers were eight times more likely to have seriously considered suicide than people who held neither role.

“These findings highlight that parents and caregivers, especially those balancing roles both as parents and caregivers, experienced higher levels of adverse mental health symptoms during the Covid-19 pandemic than adults without these responsibilities,” the authors said.

“Caregivers who had someone to rely on for support had lower odds of experiencing any adverse mental health symptoms,” they said.

The report follows innumerable anecdotes and several studies suggesting spikes in mental health problems among parents and caregivers during the pandemic. But the new C.D.C. report noted that “without prepandemic mental health data in this sample, whether adverse mental health symptoms were caused by or worsened by the pandemic is unknown.”

The study is based on data from online English-language surveys administered to panels of U.S. residents run by Qualtrics, a company that conducts commercial surveys, for the Covid-19 Outbreak Public Evaluation Initiative, an effort to track American attitudes and behaviors during the pandemic. The data was gathered from Dec. 6 to 27 last year, and from Feb. 16 to March 8 of this year, and relied on 10,444 respondents, weighted to match U.S. demographic data, 42 percent of whom identified as parents or adult caregivers.

The study noted that the results might not fully represent the U.S. population, because of factors like the surveys only being presented online and in English.

The surveys included screening items for depression, anxiety, Covid-19 trauma and stress-related disorders, and asked respondents whether they had experienced suicidal thinking in the past month. About half of the parent-caregivers who responded said that they had recently had suicidal thoughts.

Elizabeth A. Rohan, a health scientist at the C.D.C. and one of the study’s authors, said in an interview that what set this research apart was a large sample size and a broad definition of caregiver, which allowed for a more inclusive picture of people in that role.

“Our net captured more people than other surveys,” Dr. Rohan said.

Dr. Rohan said that the study reinforced the need to destigmatize mental health issues among caregivers and for better support systems. Communication is key, she said, and “it doesn’t have to be professional help.”

She added, “We cannot underestimate the importance of staying connected to one another,” which is helpful whether the person is “a trusted friend, a family member or a professional.”

If you are having thoughts of suicide, call the National Suicide Prevention Lifeline at 1-800-273-8255 (TALK). You can find a list of additional resources at SpeakingOfSuicide.com/resources.

Categories
Health

CDC Journey Tips: What You Must Know

CDC Travel Guidelines: What You Need to Know

The Centers for Disease Control and Prevention updated their guidelines for fully vaccinated Americans in April, saying that travel both domestically and internationally is a low risk.

The long-awaited recommendations were issued by federal health officials after a series of studies found that vaccines administered in the United States were robustly effective at preventing infection in real-world conditions.

One is considered fully vaccinated two weeks after receiving the single dose of the Johnson & Johnson vaccine or two weeks after receiving the second dose of the Pfizer BioNTech or Moderna shots.

When you decide to travel, you may still have a few questions. Here are the answers.

Yes. Federal law requires masks to be worn at airports in the United States, on board domestic flights, and at all transportation hubs. The CDC says that as long as coronavirus measures are in place in these scenarios, including wearing masks, fully vaccinated Americans can travel domestically without testing or quarantine, although the agency warns that some states and territories Maintain their local travel restrictions and local recommendations.

For those looking to travel internationally, a coronavirus test is not required prior to departing from the United States unless directed by the government of their destination country. Vaccinated travelers must get tested three days before flying to the United States and should have a test three to five days after their return, but do not need to quarantine themselves.

Yes, but only in countries that you have.

More than half of the world’s countries have reopened tourists from the United States, including some European Union countries that recently reopened their borders to vaccinated travelers in anticipation of the summer tourism season.

Other places like Turkey, Croatia, and Montenegro have already welcomed Americans with negative test results. Greece joined this growing list in May, ahead of most European countries, opening up to fully vaccinated tourists and other foreigners with a negative test.

Many Caribbean nations have reopened to American tourists, but each has its own coronavirus protocols and entry requirements.

Here is a full list of the countries Americans can currently travel to.

According to the CDC, when you are fully vaccinated, you can travel freely within the United States and do not need to have a test or self-quarantine before or after your trip. However, some states and local governments may choose to maintain travel restrictions, including testing, quarantine, and stay-at-home orders. Hawaii, for example, still has travel restrictions.

Before traveling across state borders, check the current rules at your destination.

For now, the best way to prove your vaccination is by showing your vaccination card.

Digital vaccination and health certificates showing that people have been vaccinated or tested are at various stages of development around the world and are expected to be used extensively to speed up travel.

The subject of “vaccine passports” is currently one of the most debated topics in the travel industry, with questions about their fair use and health and privacy concerns.

In early April Florida Governor Ron DeSantis issued an executive order that would prohibit local governments and state-owned companies from requiring proof of vaccination for services.

And in March the European Union approved its own vaccination certificate, but individual European countries are expected to set their own rules for travel requirements later this summer.

The CDC does not recommend traveling unless you have been vaccinated. If you do need to travel, the agency recommends testing one to three days before traveling and following all coronavirus guidelines in your destination.

In May, the FDA extended its emergency approval of the Pfizer BioNTech coronavirus vaccine to teenagers between the ages of 12 and 15.

All passengers aged two and over entering the United States, including those who are fully vaccinated, must have a negative Covid-19 test result no later than three days prior to boarding their flight.

The introduction of vaccinations in the US is among the fastest in the world, but there is a huge gap between their rapid introduction and vaccination programs in different countries. Some countries have not yet reported a single dose.

Many countries are currently seeing a surge in new cases and are implementing strict coronavirus protocols, including masking requirements in public spaces, capacity limits in restaurants and tourist attractions, and other lockdown restrictions.

It is important to check coronavirus case rates, measures, and medical infrastructure before traveling to your destination and not to let you down on arrival. Even if you are fully vaccinated, you may still be able to pass the disease on to local communities that have not yet been vaccinated.

Here you can follow the worldwide introduction of the coronavirus vaccination.

Follow the New York Times Travel on Instagram, Twitter and Facebook. And sign up for our weekly Travel Dispatch newsletter for expert tips on smarter travel and inspiration for your next vacation.

Categories
Health

C.D.C. Requires Up to date Childhood Vaccinations After Decline Final 12 months

C.D.C. Calls for Updated Childhood Vaccinations After Decline Last Year

Pediatricians urge U.S. parents to get their children given routine vaccinations after vaccinations for diseases such as measles declined last year as the pandemic imposed restrictions, including the arrangement of homes.

New data from 10 jurisdictions that closely monitor vaccinations confirms that the number of vaccine doses administered fell between March and May last year, particularly in older children, the Centers for Disease Control and Prevention reported Thursday.

Although vaccinations recovered between June 2020 and September 2020 and were approaching pre-pandemic levels, the increase was insufficient to offset the earlier decline, the study found.

Vaccination is required to attend most schools, camps and daycare, but the CDC study authors warned that the delay could nonetheless pose “a serious public health threat that would lead to vaccine-preventable disease outbreaks.”

They expressed concern that the move to distance learning during the pandemic may have hampered enforcement of vaccination regulations, noting that even a temporary drop in vaccination can affect herd immunity.

A measles outbreak occurred in Rockland County, NY and surrounding counties in 2018-2019 after the measles vaccination rate in schools in the area dropped to 77 percent, among the 93 to 95 percent required to maintain herd immunity are. “Pediatric outbreaks of vaccine-preventable diseases can undo efforts to reopen schools this fall,” the researchers added.

Parents should plan ahead now and make appointments so their children can be protected, said Dr. Yvonne Maldonado, Chair of the Infectious Diseases Committee at the American Academy of Pediatrics.

“We should start thinking about it,” said Dr. Maldonado in a telephone interview. “People forget. We have whooping cough outbreaks regularly every four or five years and are just waiting to see another. “

“We’ll likely see more infections because the kids will get back together and there will be less masking and social distancing,” she added.

The CDC analyzed data from nine states and New York City. In eight of the jurisdictions, a stay at home order was issued last spring.

The number of doses of diphtheria, tetanus and pertussis vaccines (DTaP) administered decreased by 15.7 percent in children under 2 years of age and in children aged from in the spring of last year compared to the same period in 2018 and 2019 2 to 6 years back by 60 percent.

The vaccine doses against measles, mumps and rubella (MMR) fell by 22.4 percent in 1-year-olds and by 63 percent in 2 to 8-year-olds.

HPV vaccine administration decreased more than 63 percent in adolescents aged 9-17 years compared to the same period in 2018 and 2019; and doses of Tdap (tetanus, diphtheria, and whooping cough) decreased by over 60 percent.

Categories
Health

C.D.C. Investigating Circumstances of Coronary heart Irritation Following Immunization

C.D.C. Investigating Cases of Heart Inflammation Following Immunization

Federal officials are reviewing nearly 800 cases of rare heart problems following immunization with the coronavirus vaccines made by Pfizer-BioNTech and Moderna, according to data presented at a vaccine safety meeting on Thursday.

Not all of the cases are likely to be verified or related to vaccines, and experts believe the benefits of immunization far outweigh the risk of these rare complications. But the reports have worried some researchers. More than half of the heart problems were reported in people ages 12 to 24, while the same age group accounted for only 9 percent of the millions of doses administered.

“We clearly have an imbalance there,” said Dr. Tom Shimabukuro, a vaccine expert at the Centers for Disease Control and Prevention who presented the data. Advisers to the agency will meet on June 18 to explore the potential links to the complications: myocarditis, inflammation of the heart muscle, and pericarditis, inflammation of the membrane surrounding the heart.

About two-thirds of the cases were in young males, with a median age of 30 years. The numbers are higher than would be expected for that age group, officials said, but have not yet been definitively linked to the vaccines.

As of May 31, 216 people had experienced myocarditis or pericarditis after one dose of either vaccine, and 573 after the second dose. Most cases have been mild, but 15 patients remain in hospitals. The second dose of the Pfizer-BioNTech vaccine was linked to about twice as many cases as the second dose of the vaccine made by Moderna.

There were 79 reported cases of the heart problems among those 16 or 17 years old, compared with a maximum of 19 cases expected for that group. And in the group of young people ages 18 to 24, there were 196 cases, compared with an expected maximum of 83.

But the true incidence may be lower, Dr. Shimabukuro said. Immunizations of younger teenagers began only last month, and data from that age group in particular are limited.